Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Stimulants | 1 | 2023 | 218 | 0.730 |
Why?
|
| Survival Analysis | 1 | 2022 | 1534 | 0.610 |
Why?
|
| Salmonella enterica | 4 | 2015 | 8 | 0.480 |
Why?
|
| HIV Infections | 1 | 2023 | 837 | 0.470 |
Why?
|
| Begomovirus | 1 | 2014 | 1 | 0.470 |
Why?
|
| Insect Control | 1 | 2014 | 4 | 0.470 |
Why?
|
| Hemiptera | 1 | 2014 | 7 | 0.460 |
Why?
|
| Insecticides | 1 | 2014 | 27 | 0.460 |
Why?
|
| Patient Transfer | 2 | 2024 | 94 | 0.430 |
Why?
|
| Agricultural Irrigation | 4 | 2015 | 4 | 0.400 |
Why?
|
| Fruit | 4 | 2017 | 76 | 0.400 |
Why?
|
| Tumor Hypoxia | 2 | 2022 | 30 | 0.390 |
Why?
|
| Food Contamination | 4 | 2017 | 32 | 0.320 |
Why?
|
| Prostatic Neoplasms | 3 | 2023 | 1768 | 0.290 |
Why?
|
| Computer Simulation | 2 | 2022 | 1097 | 0.270 |
Why?
|
| Salmonella | 2 | 2017 | 14 | 0.270 |
Why?
|
| Ponds | 2 | 2015 | 2 | 0.250 |
Why?
|
| Misonidazole | 2 | 2022 | 17 | 0.240 |
Why?
|
| Stroke | 2 | 2023 | 985 | 0.240 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 113 | 0.220 |
Why?
|
| Gender Identity | 1 | 2023 | 53 | 0.220 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 521 | 0.220 |
Why?
|
| Rural Population | 1 | 2023 | 143 | 0.210 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 182 | 0.200 |
Why?
|
| Febrile Neutropenia | 1 | 2022 | 14 | 0.200 |
Why?
|
| Humans | 24 | 2024 | 89157 | 0.200 |
Why?
|
| Zinc | 1 | 2021 | 93 | 0.190 |
Why?
|
| Neoplasms | 3 | 2022 | 3037 | 0.190 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2021 | 58 | 0.190 |
Why?
|
| Pneumonia | 1 | 2022 | 182 | 0.190 |
Why?
|
| Probability | 1 | 2022 | 353 | 0.190 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 162 | 0.180 |
Why?
|
| Brachytherapy | 1 | 2021 | 121 | 0.180 |
Why?
|
| Rectum | 1 | 2021 | 148 | 0.180 |
Why?
|
| Symptom Assessment | 1 | 2020 | 66 | 0.180 |
Why?
|
| Antibody Formation | 1 | 2020 | 171 | 0.180 |
Why?
|
| Triiodothyronine | 1 | 2021 | 344 | 0.180 |
Why?
|
| Male | 12 | 2024 | 42309 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2022 | 302 | 0.170 |
Why?
|
| Dietary Supplements | 2 | 2018 | 125 | 0.170 |
Why?
|
| Mesothelioma | 1 | 2022 | 323 | 0.170 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 309 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 442 | 0.160 |
Why?
|
| Oxygen | 2 | 2021 | 742 | 0.160 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 295 | 0.160 |
Why?
|
| Quercetin | 1 | 2018 | 3 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2018 | 10 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1709 | 0.150 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 281 | 0.150 |
Why?
|
| Health Personnel | 1 | 2020 | 213 | 0.150 |
Why?
|
| Community Health Centers | 1 | 2019 | 115 | 0.150 |
Why?
|
| Patient Care Team | 1 | 2020 | 283 | 0.150 |
Why?
|
| Female | 11 | 2024 | 46078 | 0.150 |
Why?
|
| Digestion | 1 | 2017 | 8 | 0.150 |
Why?
|
| Animal Feed | 1 | 2017 | 20 | 0.150 |
Why?
|
| Health Promotion | 1 | 2019 | 163 | 0.140 |
Why?
|
| Milk | 1 | 2017 | 53 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 44 | 0.140 |
Why?
|
| Retrospective Studies | 7 | 2024 | 9022 | 0.140 |
Why?
|
| Enzymes | 1 | 2017 | 47 | 0.140 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 157 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2019 | 341 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 1096 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2019 | 346 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 890 | 0.120 |
Why?
|
| Electron Spin Resonance Spectroscopy | 3 | 2022 | 317 | 0.120 |
Why?
|
| Capsicum | 1 | 2014 | 2 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 736 | 0.120 |
Why?
|
| Fertilizers | 1 | 2014 | 8 | 0.120 |
Why?
|
| Vegetables | 1 | 2014 | 47 | 0.120 |
Why?
|
| Aged | 8 | 2024 | 19119 | 0.120 |
Why?
|
| Salmonella Food Poisoning | 1 | 2013 | 4 | 0.120 |
Why?
|
| Bacteriological Techniques | 1 | 2014 | 39 | 0.120 |
Why?
|
| Nitrogen | 1 | 2014 | 73 | 0.120 |
Why?
|
| Middle Aged | 9 | 2024 | 25910 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 1194 | 0.110 |
Why?
|
| Potassium | 1 | 2014 | 253 | 0.110 |
Why?
|
| Adult | 5 | 2023 | 26542 | 0.110 |
Why?
|
| Physicians | 1 | 2020 | 690 | 0.100 |
Why?
|
| Hypoxia | 3 | 2022 | 650 | 0.100 |
Why?
|
| Time Factors | 4 | 2024 | 5331 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2023 | 783 | 0.090 |
Why?
|
| United States | 4 | 2024 | 6965 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 336 | 0.090 |
Why?
|
| Registries | 2 | 2024 | 780 | 0.080 |
Why?
|
| Prostate | 2 | 2023 | 393 | 0.080 |
Why?
|
| Seasons | 3 | 2015 | 237 | 0.080 |
Why?
|
| Food Handling | 2 | 2017 | 6 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3444 | 0.070 |
Why?
|
| Animals | 4 | 2022 | 27330 | 0.060 |
Why?
|
| Cerebral Infarction | 1 | 2023 | 72 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6794 | 0.050 |
Why?
|
| Margins of Excision | 1 | 2022 | 39 | 0.050 |
Why?
|
| Aspirin | 1 | 2023 | 159 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2023 | 143 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 66 | 0.050 |
Why?
|
| Motion | 1 | 2022 | 93 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 46 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 232 | 0.050 |
Why?
|
| Compliance | 1 | 2021 | 21 | 0.050 |
Why?
|
| Quality of Life | 2 | 2021 | 1665 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 141 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2023 | 229 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2022 | 170 | 0.050 |
Why?
|
| Acute Disease | 1 | 2023 | 841 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2022 | 119 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 193 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 85 | 0.050 |
Why?
|
| Pressure | 1 | 2021 | 165 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2022 | 485 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2021 | 69 | 0.050 |
Why?
|
| Radiotherapy Dosage | 1 | 2021 | 470 | 0.050 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2021 | 76 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 848 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 93 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2022 | 187 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 32 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 222 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 120 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 2021 | 241 | 0.040 |
Why?
|
| Nigeria | 1 | 2020 | 156 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 1848 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2023 | 400 | 0.040 |
Why?
|
| Population Health | 1 | 2019 | 33 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 464 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 860 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1715 | 0.040 |
Why?
|
| Mice | 2 | 2022 | 11743 | 0.040 |
Why?
|
| Dairying | 1 | 2017 | 3 | 0.040 |
Why?
|
| Endo-1,4-beta Xylanases | 1 | 2017 | 3 | 0.040 |
Why?
|
| Cellulase | 1 | 2017 | 2 | 0.040 |
Why?
|
| Poverty | 1 | 2019 | 180 | 0.040 |
Why?
|
| Milk Proteins | 1 | 2017 | 24 | 0.040 |
Why?
|
| Lipid Droplets | 1 | 2017 | 16 | 0.040 |
Why?
|
| Glycolipids | 1 | 2017 | 29 | 0.040 |
Why?
|
| Lactation | 1 | 2017 | 54 | 0.040 |
Why?
|
| Humidity | 1 | 2017 | 92 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1855 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1720 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 375 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8217 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 771 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 2002 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2022 | 1239 | 0.030 |
Why?
|
| Eating | 1 | 2017 | 166 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2753 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2017 | 234 | 0.030 |
Why?
|
| Temperature | 1 | 2017 | 400 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1837 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2015 | 18 | 0.030 |
Why?
|
| Georgia | 1 | 2015 | 35 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2015 | 17 | 0.030 |
Why?
|
| Florida | 1 | 2015 | 57 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 868 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 75 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 149 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 1424 | 0.030 |
Why?
|
| Culture Media | 1 | 2014 | 147 | 0.030 |
Why?
|
| Food Microbiology | 1 | 2013 | 9 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 684 | 0.030 |
Why?
|
| Bacterial Typing Techniques | 1 | 2013 | 28 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 442 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1798 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 4281 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 195 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2658 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 922 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 5483 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1763 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7154 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 6294 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 786 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2014 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 9243 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2015 | 1371 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1650 | 0.020 |
Why?
|